These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31972319)

  • 1. Inter-technique variability between antimicrobial susceptibility testing methods affects clinical classification of cefuroxime in strains close to breakpoint.
    Ballestero-Téllez M; Jiménez-Morgades E; Arjona-Camacho P; Blanco-Suárez A; Padilla-Esteba E; Pérez-Jové J
    Clin Microbiol Infect; 2020 May; 26(5):648.e1-648.e3. PubMed ID: 31972319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Area of technical uncertainty for susceptibility testing of amoxicillin/clavulanate against Escherichia coli: analysis of automated system, Etest and disk diffusion methods compared to the broth microdilution reference.
    Soares A; Pestel-Caron M; Leysour de Rohello F; Bourgoin G; Boyer S; Caron F
    Clin Microbiol Infect; 2020 Dec; 26(12):1685.e1-1685.e6. PubMed ID: 32151599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
    Bengtsson S; Bjelkenbrant C; Kahlmeter G
    Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
    Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
    Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative performance of antimicrobial susceptibility assays on clinical Escherichia coli isolates from animals.
    Badger S; Abraham S; Saputra S; Trott DJ; Turnidge J; Mitchell T; Caraguel CGB; Jordan D
    Vet Microbiol; 2018 Feb; 214():56-64. PubMed ID: 29408033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
    Leverstein-van Hall MA; Waar K; Muilwijk J; Cohen Stuart J;
    J Antimicrob Chemother; 2013 Nov; 68(11):2636-40. PubMed ID: 23766488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B Etest
    Kulengowski B; Ribes JA; Burgess DS
    Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
    Matuschek E; Åhman J; Webster C; Kahlmeter G
    Clin Microbiol Infect; 2018 Aug; 24(8):865-870. PubMed ID: 29221995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
    Süzük S; Kaşkatepe B; Avcıküçük H; Aksaray S; Başustaoğlu A
    Mikrobiyol Bul; 2015 Oct; 49(4):494-501. PubMed ID: 26649407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli.
    Antonelli A; Coppi M; Camarlinghi G; Parisio EM; Nardone M; Riccobono E; Giani T; Mattei R; Rossolini GM
    Clin Microbiol Infect; 2019 Nov; 25(11):1432.e1-1432.e4. PubMed ID: 31425743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
    Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
    J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol.
    Devoos L; Biguenet A; Rousselot J; Bour M; Plésiat P; Fournier D; Jeannot K
    Clin Microbiol Infect; 2023 May; 29(5):652.e1-652.e8. PubMed ID: 36587736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
    Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
    J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2020 Nov; 26(11):1488-1492. PubMed ID: 32750539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes.
    Díez-Aguilar M; Morosini MI; López-Cerero L; Pascual Á; Calvo J; Martínez-Martínez L; Marco F; Vila J; Ortega A; Oteo J; Cantón R
    J Antimicrob Chemother; 2015 Aug; 70(8):2306-10. PubMed ID: 25900161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
    Huhulescu S; Sagel U; Fiedler A; Pecavar V; Blaschitz M; Wewalka G; Allerberger F; Indra A
    J Med Microbiol; 2011 Aug; 60(Pt 8):1206-1212. PubMed ID: 21292853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.